Global Covid-19 Rapid Antigen Market Growth 2023-2028

Report ID: 1544835 | Published Date: Jan 2025 | No. of Page: 121 | Base Year: 2024 | Rating: 4.9 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Scope of the Report
    1.1 Market Introduction
    1.2 Years Considered
    1.3 Research Objectives
    1.4 Market Research Methodology
    1.5 Research Process and Data Source
    1.6 Economic Indicators
    1.7 Currency Considered
2 Executive Summary
    2.1 World Market Overview
        2.1.1 Global Covid-19 Rapid Antigen Annual Sales 2017-2028
        2.1.2 World Current & Future Analysis for Covid-19 Rapid Antigen by Geographic Region, 2017, 2022 & 2028
        2.1.3 World Current & Future Analysis for Covid-19 Rapid Antigen by Country/Region, 2017, 2022 & 2028
    2.2 Covid-19 Rapid Antigen Segment by Sample Type
        2.2.1 Nasal Swab
        2.2.2 Oral Fluid/Saliva
    2.3 Covid-19 Rapid Antigen Sales by Sample Type
        2.3.1 Global Covid-19 Rapid Antigen Sales Market Share by Sample Type (2017-2022)
        2.3.2 Global Covid-19 Rapid Antigen Revenue and Market Share by Sample Type (2017-2022)
        2.3.3 Global Covid-19 Rapid Antigen Sale Price by Sample Type (2017-2022)
    2.4 Covid-19 Rapid Antigen Segment by Application
        2.4.1 Hospitals
        2.4.2 Scientific Research
    2.5 Covid-19 Rapid Antigen Sales by Application
        2.5.1 Global Covid-19 Rapid Antigen Sale Market Share by Application (2017-2022)
        2.5.2 Global Covid-19 Rapid Antigen Revenue and Market Share by Application (2017-2022)
        2.5.3 Global Covid-19 Rapid Antigen Sale Price by Application (2017-2022)
3 Global Covid-19 Rapid Antigen by Company
    3.1 Global Covid-19 Rapid Antigen Breakdown Data by Company
        3.1.1 Global Covid-19 Rapid Antigen Annual Sales by Company (2020-2022)
        3.1.2 Global Covid-19 Rapid Antigen Sales Market Share by Company (2020-2022)
    3.2 Global Covid-19 Rapid Antigen Annual Revenue by Company (2020-2022)
        3.2.1 Global Covid-19 Rapid Antigen Revenue by Company (2020-2022)
        3.2.2 Global Covid-19 Rapid Antigen Revenue Market Share by Company (2020-2022)
    3.3 Global Covid-19 Rapid Antigen Sale Price by Company
    3.4 Key Manufacturers Covid-19 Rapid Antigen Producing Area Distribution, Sales Area, Product Type
        3.4.1 Key Manufacturers Covid-19 Rapid Antigen Product Location Distribution
        3.4.2 Players Covid-19 Rapid Antigen Products Offered
    3.5 Market Concentration Rate Analysis
        3.5.1 Competition Landscape Analysis
        3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
    3.6 New Products and Potential Entrants
    3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Covid-19 Rapid Antigen by Geographic Region
    4.1 World Historic Covid-19 Rapid Antigen Market Size by Geographic Region (2017-2022)
        4.1.1 Global Covid-19 Rapid Antigen Annual Sales by Geographic Region (2017-2022)
        4.1.2 Global Covid-19 Rapid Antigen Annual Revenue by Geographic Region
    4.2 World Historic Covid-19 Rapid Antigen Market Size by Country/Region (2017-2022)
        4.2.1 Global Covid-19 Rapid Antigen Annual Sales by Country/Region (2017-2022)
        4.2.2 Global Covid-19 Rapid Antigen Annual Revenue by Country/Region
    4.3 Americas Covid-19 Rapid Antigen Sales Growth
    4.4 APAC Covid-19 Rapid Antigen Sales Growth
    4.5 Europe Covid-19 Rapid Antigen Sales Growth
    4.6 Middle East & Africa Covid-19 Rapid Antigen Sales Growth
5 Americas
    5.1 Americas Covid-19 Rapid Antigen Sales by Country
        5.1.1 Americas Covid-19 Rapid Antigen Sales by Country (2017-2022)
        5.1.2 Americas Covid-19 Rapid Antigen Revenue by Country (2017-2022)
    5.2 Americas Covid-19 Rapid Antigen Sales by Sample Type
    5.3 Americas Covid-19 Rapid Antigen Sales by Application
    5.4 United States
    5.5 Canada
    5.6 Mexico
    5.7 Brazil
6 APAC
    6.1 APAC Covid-19 Rapid Antigen Sales by Region
        6.1.1 APAC Covid-19 Rapid Antigen Sales by Region (2017-2022)
        6.1.2 APAC Covid-19 Rapid Antigen Revenue by Region (2017-2022)
    6.2 APAC Covid-19 Rapid Antigen Sales by Sample Type
    6.3 APAC Covid-19 Rapid Antigen Sales by Application
    6.4 China
    6.5 Japan
    6.6 South Korea
    6.7 Southeast Asia
    6.8 India
    6.9 Australia
    6.10 China Taiwan
7 Europe
    7.1 Europe Covid-19 Rapid Antigen by Country
        7.1.1 Europe Covid-19 Rapid Antigen Sales by Country (2017-2022)
        7.1.2 Europe Covid-19 Rapid Antigen Revenue by Country (2017-2022)
    7.2 Europe Covid-19 Rapid Antigen Sales by Sample Type
    7.3 Europe Covid-19 Rapid Antigen Sales by Application
    7.4 Germany
    7.5 France
    7.6 UK
    7.7 Italy
    7.8 Russia
8 Middle East & Africa
    8.1 Middle East & Africa Covid-19 Rapid Antigen by Country
        8.1.1 Middle East & Africa Covid-19 Rapid Antigen Sales by Country (2017-2022)
        8.1.2 Middle East & Africa Covid-19 Rapid Antigen Revenue by Country (2017-2022)
    8.2 Middle East & Africa Covid-19 Rapid Antigen Sales by Sample Type
    8.3 Middle East & Africa Covid-19 Rapid Antigen Sales by Application
    8.4 Egypt
    8.5 South Africa
    8.6 Israel
    8.7 Turkey
    8.8 GCC Countries
9 Market Drivers, Challenges and Trends
    9.1 Market Drivers & Growth Opportunities
    9.2 Market Challenges & Risks
    9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
    10.1 Raw Material and Suppliers
    10.2 Manufacturing Cost Structure Analysis of Covid-19 Rapid Antigen
    10.3 Manufacturing Process Analysis of Covid-19 Rapid Antigen
    10.4 Industry Chain Structure of Covid-19 Rapid Antigen
11 Marketing, Distributors and Customer
    11.1 Sales Channel
        11.1.1 Direct Channels
        11.1.2 Indirect Channels
    11.2 Covid-19 Rapid Antigen Distributors
    11.3 Covid-19 Rapid Antigen Customer
12 World Forecast Review for Covid-19 Rapid Antigen by Geographic Region
    12.1 Global Covid-19 Rapid Antigen Market Size Forecast by Region
        12.1.1 Global Covid-19 Rapid Antigen Forecast by Region (2023-2028)
        12.1.2 Global Covid-19 Rapid Antigen Annual Revenue Forecast by Region (2023-2028)
    12.2 Americas Forecast by Country
    12.3 APAC Forecast by Region
    12.4 Europe Forecast by Country
    12.5 Middle East & Africa Forecast by Country
    12.6 Global Covid-19 Rapid Antigen Forecast by Sample Type
    12.7 Global Covid-19 Rapid Antigen Forecast by Application
13 Key Players Analysis
    13.1 Abbott
        13.1.1 Abbott Company Information
        13.1.2 Abbott Covid-19 Rapid Antigen Product Offered
        13.1.3 Abbott Covid-19 Rapid Antigen Sales, Revenue, Price and Gross Margin (2020-2022)
        13.1.4 Abbott Main Business Overview
        13.1.5 Abbott Latest Developments
    13.2 Access Bio
        13.2.1 Access Bio Company Information
        13.2.2 Access Bio Covid-19 Rapid Antigen Product Offered
        13.2.3 Access Bio Covid-19 Rapid Antigen Sales, Revenue, Price and Gross Margin (2020-2022)
        13.2.4 Access Bio Main Business Overview
        13.2.5 Access Bio Latest Developments
    13.3 BD
        13.3.1 BD Company Information
        13.3.2 BD Covid-19 Rapid Antigen Product Offered
        13.3.3 BD Covid-19 Rapid Antigen Sales, Revenue, Price and Gross Margin (2020-2022)
        13.3.4 BD Main Business Overview
        13.3.5 BD Latest Developments
    13.4 Quidel
        13.4.1 Quidel Company Information
        13.4.2 Quidel Covid-19 Rapid Antigen Product Offered
        13.4.3 Quidel Covid-19 Rapid Antigen Sales, Revenue, Price and Gross Margin (2020-2022)
        13.4.4 Quidel Main Business Overview
        13.4.5 Quidel Latest Developments
    13.5 Fujirebio
        13.5.1 Fujirebio Company Information
        13.5.2 Fujirebio Covid-19 Rapid Antigen Product Offered
        13.5.3 Fujirebio Covid-19 Rapid Antigen Sales, Revenue, Price and Gross Margin (2020-2022)
        13.5.4 Fujirebio Main Business Overview
        13.5.5 Fujirebio Latest Developments
    13.6 Ellume
        13.6.1 Ellume Company Information
        13.6.2 Ellume Covid-19 Rapid Antigen Product Offered
        13.6.3 Ellume Covid-19 Rapid Antigen Sales, Revenue, Price and Gross Margin (2020-2022)
        13.6.4 Ellume Main Business Overview
        13.6.5 Ellume Latest Developments
    13.7 OraSure Technologies
        13.7.1 OraSure Technologies Company Information
        13.7.2 OraSure Technologies Covid-19 Rapid Antigen Product Offered
        13.7.3 OraSure Technologies Covid-19 Rapid Antigen Sales, Revenue, Price and Gross Margin (2020-2022)
        13.7.4 OraSure Technologies Main Business Overview
        13.7.5 OraSure Technologies Latest Developments
    13.8 Clip Health
        13.8.1 Clip Health Company Information
        13.8.2 Clip Health Covid-19 Rapid Antigen Product Offered
        13.8.3 Clip Health Covid-19 Rapid Antigen Sales, Revenue, Price and Gross Margin (2020-2022)
        13.8.4 Clip Health Main Business Overview
        13.8.5 Clip Health Latest Developments
    13.9 Celltrion Healthcare
        13.9.1 Celltrion Healthcare Company Information
        13.9.2 Celltrion Healthcare Covid-19 Rapid Antigen Product Offered
        13.9.3 Celltrion Healthcare Covid-19 Rapid Antigen Sales, Revenue, Price and Gross Margin (2020-2022)
        13.9.4 Celltrion Healthcare Main Business Overview
        13.9.5 Celltrion Healthcare Latest Developments
    13.10 Salofa Oy
        13.10.1 Salofa Oy Company Information
        13.10.2 Salofa Oy Covid-19 Rapid Antigen Product Offered
        13.10.3 Salofa Oy Covid-19 Rapid Antigen Sales, Revenue, Price and Gross Margin (2020-2022)
        13.10.4 Salofa Oy Main Business Overview
        13.10.5 Salofa Oy Latest Developments
    13.11 iHealth Labs
        13.11.1 iHealth Labs Company Information
        13.11.2 iHealth Labs Covid-19 Rapid Antigen Product Offered
        13.11.3 iHealth Labs Covid-19 Rapid Antigen Sales, Revenue, Price and Gross Margin (2020-2022)
        13.11.4 iHealth Labs Main Business Overview
        13.11.5 iHealth Labs Latest Developments
    13.12 Novegent
        13.12.1 Novegent Company Information
        13.12.2 Novegent Covid-19 Rapid Antigen Product Offered
        13.12.3 Novegent Covid-19 Rapid Antigen Sales, Revenue, Price and Gross Margin (2020-2022)
        13.12.4 Novegent Main Business Overview
        13.12.5 Novegent Latest Developments
    13.13 Hangzhou Alltest Biotech
        13.13.1 Hangzhou Alltest Biotech Company Information
        13.13.2 Hangzhou Alltest Biotech Covid-19 Rapid Antigen Product Offered
        13.13.3 Hangzhou Alltest Biotech Covid-19 Rapid Antigen Sales, Revenue, Price and Gross Margin (2020-2022)
        13.13.4 Hangzhou Alltest Biotech Main Business Overview
        13.13.5 Hangzhou Alltest Biotech Latest Developments
    13.14 Guangzhou Decheng Biotechnology
        13.14.1 Guangzhou Decheng Biotechnology Company Information
        13.14.2 Guangzhou Decheng Biotechnology Covid-19 Rapid Antigen Product Offered
        13.14.3 Guangzhou Decheng Biotechnology Covid-19 Rapid Antigen Sales, Revenue, Price and Gross Margin (2020-2022)
        13.14.4 Guangzhou Decheng Biotechnology Main Business Overview
        13.14.5 Guangzhou Decheng Biotechnology Latest Developments
    13.15 SD Biosensor
        13.15.1 SD Biosensor Company Information
        13.15.2 SD Biosensor Covid-19 Rapid Antigen Product Offered
        13.15.3 SD Biosensor Covid-19 Rapid Antigen Sales, Revenue, Price and Gross Margin (2020-2022)
        13.15.4 SD Biosensor Main Business Overview
        13.15.5 SD Biosensor Latest Developments
    13.16 MP Biomedical
        13.16.1 MP Biomedical Company Information
        13.16.2 MP Biomedical Covid-19 Rapid Antigen Product Offered
        13.16.3 MP Biomedical Covid-19 Rapid Antigen Sales, Revenue, Price and Gross Margin (2020-2022)
        13.16.4 MP Biomedical Main Business Overview
        13.16.5 MP Biomedical Latest Developments
    13.17 Jiangsu Well Biotech
        13.17.1 Jiangsu Well Biotech Company Information
        13.17.2 Jiangsu Well Biotech Covid-19 Rapid Antigen Product Offered
        13.17.3 Jiangsu Well Biotech Covid-19 Rapid Antigen Sales, Revenue, Price and Gross Margin (2020-2022)
        13.17.4 Jiangsu Well Biotech Main Business Overview
        13.17.5 Jiangsu Well Biotech Latest Developments
    13.18 CTK Biotech
        13.18.1 CTK Biotech Company Information
        13.18.2 CTK Biotech Covid-19 Rapid Antigen Product Offered
        13.18.3 CTK Biotech Covid-19 Rapid Antigen Sales, Revenue, Price and Gross Margin (2020-2022)
        13.18.4 CTK Biotech Main Business Overview
        13.18.5 CTK Biotech Latest Developments
    13.19 Hangzhou Laihe Biotech
        13.19.1 Hangzhou Laihe Biotech Company Information
        13.19.2 Hangzhou Laihe Biotech Covid-19 Rapid Antigen Product Offered
        13.19.3 Hangzhou Laihe Biotech Covid-19 Rapid Antigen Sales, Revenue, Price and Gross Margin (2020-2022)
        13.19.4 Hangzhou Laihe Biotech Main Business Overview
        13.19.5 Hangzhou Laihe Biotech Latest Developments
    13.20 Innovation Scientific
        13.20.1 Innovation Scientific Company Information
        13.20.2 Innovation Scientific Covid-19 Rapid Antigen Product Offered
        13.20.3 Innovation Scientific Covid-19 Rapid Antigen Sales, Revenue, Price and Gross Margin (2020-2022)
        13.20.4 Innovation Scientific Main Business Overview
        13.20.5 Innovation Scientific Latest Developments
    13.21 Biohit Healthcare
        13.21.1 Biohit Healthcare Company Information
        13.21.2 Biohit Healthcare Covid-19 Rapid Antigen Product Offered
        13.21.3 Biohit Healthcare Covid-19 Rapid Antigen Sales, Revenue, Price and Gross Margin (2020-2022)
        13.21.4 Biohit Healthcare Main Business Overview
        13.21.5 Biohit Healthcare Latest Developments
    13.22 ACON Biotech
        13.22.1 ACON Biotech Company Information
        13.22.2 ACON Biotech Covid-19 Rapid Antigen Product Offered
        13.22.3 ACON Biotech Covid-19 Rapid Antigen Sales, Revenue, Price and Gross Margin (2020-2022)
        13.22.4 ACON Biotech Main Business Overview
        13.22.5 ACON Biotech Latest Developments
    13.23 Assure Tech
        13.23.1 Assure Tech Company Information
        13.23.2 Assure Tech Covid-19 Rapid Antigen Product Offered
        13.23.3 Assure Tech Covid-19 Rapid Antigen Sales, Revenue, Price and Gross Margin (2020-2022)
        13.23.4 Assure Tech Main Business Overview
        13.23.5 Assure Tech Latest Developments
    13.24 Hangzhou Clongene Biotech
        13.24.1 Hangzhou Clongene Biotech Company Information
        13.24.2 Hangzhou Clongene Biotech Covid-19 Rapid Antigen Product Offered
        13.24.3 Hangzhou Clongene Biotech Covid-19 Rapid Antigen Sales, Revenue, Price and Gross Margin (2020-2022)
        13.24.4 Hangzhou Clongene Biotech Main Business Overview
        13.24.5 Hangzhou Clongene Biotech Latest Developments
    13.25 Hangzhou Testsea Biotechnology
        13.25.1 Hangzhou Testsea Biotechnology Company Information
        13.25.2 Hangzhou Testsea Biotechnology Covid-19 Rapid Antigen Product Offered
        13.25.3 Hangzhou Testsea Biotechnology Covid-19 Rapid Antigen Sales, Revenue, Price and Gross Margin (2020-2022)
        13.25.4 Hangzhou Testsea Biotechnology Main Business Overview
        13.25.5 Hangzhou Testsea Biotechnology Latest Developments
14 Research Findings and Conclusion

List of Tables
    Table 1. Covid-19 Rapid Antigen Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
    Table 2. Covid-19 Rapid Antigen Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
    Table 3. Major Players of Nasal Swab
    Table 4. Major Players of Oral Fluid/Saliva
    Table 5. Global Covid-19 Rapid Antigen Sales by Sample Type (2017-2022) & (K Units)
    Table 6. Global Covid-19 Rapid Antigen Sales Market Share by Sample Type (2017-2022)
    Table 7. Global Covid-19 Rapid Antigen Revenue by Sample Type (2017-2022) & ($ million)
    Table 8. Global Covid-19 Rapid Antigen Revenue Market Share by Sample Type (2017-2022)
    Table 9. Global Covid-19 Rapid Antigen Sale Price by Sample Type (2017-2022) & (US$/Unit)
    Table 10. Global Covid-19 Rapid Antigen Sales by Application (2017-2022) & (K Units)
    Table 11. Global Covid-19 Rapid Antigen Sales Market Share by Application (2017-2022)
    Table 12. Global Covid-19 Rapid Antigen Revenue by Application (2017-2022)
    Table 13. Global Covid-19 Rapid Antigen Revenue Market Share by Application (2017-2022)
    Table 14. Global Covid-19 Rapid Antigen Sale Price by Application (2017-2022) & (US$/Unit)
    Table 15. Global Covid-19 Rapid Antigen Sales by Company (2020-2022) & (K Units)
    Table 16. Global Covid-19 Rapid Antigen Sales Market Share by Company (2020-2022)
    Table 17. Global Covid-19 Rapid Antigen Revenue by Company (2020-2022) ($ Millions)
    Table 18. Global Covid-19 Rapid Antigen Revenue Market Share by Company (2020-2022)
    Table 19. Global Covid-19 Rapid Antigen Sale Price by Company (2020-2022) & (US$/Unit)
    Table 20. Key Manufacturers Covid-19 Rapid Antigen Producing Area Distribution and Sales Area
    Table 21. Players Covid-19 Rapid Antigen Products Offered
    Table 22. Covid-19 Rapid Antigen Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
    Table 23. New Products and Potential Entrants
    Table 24. Mergers & Acquisitions, Expansion
    Table 25. Global Covid-19 Rapid Antigen Sales by Geographic Region (2017-2022) & (K Units)
    Table 26. Global Covid-19 Rapid Antigen Sales Market Share Geographic Region (2017-2022)
    Table 27. Global Covid-19 Rapid Antigen Revenue by Geographic Region (2017-2022) & ($ millions)
    Table 28. Global Covid-19 Rapid Antigen Revenue Market Share by Geographic Region (2017-2022)
    Table 29. Global Covid-19 Rapid Antigen Sales by Country/Region (2017-2022) & (K Units)
    Table 30. Global Covid-19 Rapid Antigen Sales Market Share by Country/Region (2017-2022)
    Table 31. Global Covid-19 Rapid Antigen Revenue by Country/Region (2017-2022) & ($ millions)
    Table 32. Global Covid-19 Rapid Antigen Revenue Market Share by Country/Region (2017-2022)
    Table 33. Americas Covid-19 Rapid Antigen Sales by Country (2017-2022) & (K Units)
    Table 34. Americas Covid-19 Rapid Antigen Sales Market Share by Country (2017-2022)
    Table 35. Americas Covid-19 Rapid Antigen Revenue by Country (2017-2022) & ($ Millions)
    Table 36. Americas Covid-19 Rapid Antigen Revenue Market Share by Country (2017-2022)
    Table 37. Americas Covid-19 Rapid Antigen Sales by Type (2017-2022) & (K Units)
    Table 38. Americas Covid-19 Rapid Antigen Sales Market Share by Sample Type (2017-2022)
    Table 39. Americas Covid-19 Rapid Antigen Sales by Application (2017-2022) & (K Units)
    Table 40. Americas Covid-19 Rapid Antigen Sales Market Share by Application (2017-2022)
    Table 41. APAC Covid-19 Rapid Antigen Sales by Region (2017-2022) & (K Units)
    Table 42. APAC Covid-19 Rapid Antigen Sales Market Share by Region (2017-2022)
    Table 43. APAC Covid-19 Rapid Antigen Revenue by Region (2017-2022) & ($ Millions)
    Table 44. APAC Covid-19 Rapid Antigen Revenue Market Share by Region (2017-2022)
    Table 45. APAC Covid-19 Rapid Antigen Sales by Sample Type (2017-2022) & (K Units)
    Table 46. APAC Covid-19 Rapid Antigen Sales Market Share by Sample Type (2017-2022)
    Table 47. APAC Covid-19 Rapid Antigen Sales by Application (2017-2022) & (K Units)
    Table 48. APAC Covid-19 Rapid Antigen Sales Market Share by Application (2017-2022)
    Table 49. Europe Covid-19 Rapid Antigen Sales by Country (2017-2022) & (K Units)
    Table 50. Europe Covid-19 Rapid Antigen Sales Market Share by Country (2017-2022)
    Table 51. Europe Covid-19 Rapid Antigen Revenue by Country (2017-2022) & ($ Millions)
    Table 52. Europe Covid-19 Rapid Antigen Revenue Market Share by Country (2017-2022)
    Table 53. Europe Covid-19 Rapid Antigen Sales by Type (2017-2022) & (K Units)
    Table 54. Europe Covid-19 Rapid Antigen Sales Market Share by Sample Type (2017-2022)
    Table 55. Europe Covid-19 Rapid Antigen Sales by Application (2017-2022) & (K Units)
    Table 56. Europe Covid-19 Rapid Antigen Sales Market Share by Application (2017-2022)
    Table 57. Middle East & Africa Covid-19 Rapid Antigen Sales by Country (2017-2022) & (K Units)
    Table 58. Middle East & Africa Covid-19 Rapid Antigen Sales Market Share by Country (2017-2022)
    Table 59. Middle East & Africa Covid-19 Rapid Antigen Revenue by Country (2017-2022) & ($ Millions)
    Table 60. Middle East & Africa Covid-19 Rapid Antigen Revenue Market Share by Country (2017-2022)
    Table 61. Middle East & Africa Covid-19 Rapid Antigen Sales by Sample Type (2017-2022) & (K Units)
    Table 62. Middle East & Africa Covid-19 Rapid Antigen Sales Market Share by Sample Type (2017-2022)
    Table 63. Middle East & Africa Covid-19 Rapid Antigen Sales by Application (2017-2022) & (K Units)
    Table 64. Middle East & Africa Covid-19 Rapid Antigen Sales Market Share by Application (2017-2022)
    Table 65. Key Market Drivers & Growth Opportunities of Covid-19 Rapid Antigen
    Table 66. Key Market Challenges & Risks of Covid-19 Rapid Antigen
    Table 67. Key Industry Trends of Covid-19 Rapid Antigen
    Table 68. Covid-19 Rapid Antigen Raw Material
    Table 69. Key Suppliers of Raw Materials
    Table 70. Covid-19 Rapid Antigen Distributors List
    Table 71. Covid-19 Rapid Antigen Customer List
    Table 72. Global Covid-19 Rapid Antigen Sales Forecast by Region (2023-2028) & (K Units)
    Table 73. Global Covid-19 Rapid Antigen Sales Market Forecast by Region
    Table 74. Global Covid-19 Rapid Antigen Revenue Forecast by Region (2023-2028) & ($ millions)
    Table 75. Global Covid-19 Rapid Antigen Revenue Market Share Forecast by Region (2023-2028)
    Table 76. Americas Covid-19 Rapid Antigen Sales Forecast by Country (2023-2028) & (K Units)
    Table 77. Americas Covid-19 Rapid Antigen Revenue Forecast by Country (2023-2028) & ($ millions)
    Table 78. APAC Covid-19 Rapid Antigen Sales Forecast by Region (2023-2028) & (K Units)
    Table 79. APAC Covid-19 Rapid Antigen Revenue Forecast by Region (2023-2028) & ($ millions)
    Table 80. Europe Covid-19 Rapid Antigen Sales Forecast by Country (2023-2028) & (K Units)
    Table 81. Europe Covid-19 Rapid Antigen Revenue Forecast by Country (2023-2028) & ($ millions)
    Table 82. Middle East & Africa Covid-19 Rapid Antigen Sales Forecast by Country (2023-2028) & (K Units)
    Table 83. Middle East & Africa Covid-19 Rapid Antigen Revenue Forecast by Country (2023-2028) & ($ millions)
    Table 84. Global Covid-19 Rapid Antigen Sales Forecast by Sample Type (2023-2028) & (K Units)
    Table 85. Global Covid-19 Rapid Antigen Sales Market Share Forecast by Sample Type (2023-2028)
    Table 86. Global Covid-19 Rapid Antigen Revenue Forecast by Sample Type (2023-2028) & ($ Millions)
    Table 87. Global Covid-19 Rapid Antigen Revenue Market Share Forecast by Sample Type (2023-2028)
    Table 88. Global Covid-19 Rapid Antigen Sales Forecast by Application (2023-2028) & (K Units)
    Table 89. Global Covid-19 Rapid Antigen Sales Market Share Forecast by Application (2023-2028)
    Table 90. Global Covid-19 Rapid Antigen Revenue Forecast by Application (2023-2028) & ($ Millions)
    Table 91. Global Covid-19 Rapid Antigen Revenue Market Share Forecast by Application (2023-2028)
    Table 92. Abbott Basic Information, Covid-19 Rapid Antigen Manufacturing Base, Sales Area and Its Competitors
    Table 93. Abbott Covid-19 Rapid Antigen Product Offered
    Table 94. Abbott Covid-19 Rapid Antigen Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
    Table 95. Abbott Main Business
    Table 96. Abbott Latest Developments
    Table 97. Access Bio Basic Information, Covid-19 Rapid Antigen Manufacturing Base, Sales Area and Its Competitors
    Table 98. Access Bio Covid-19 Rapid Antigen Product Offered
    Table 99. Access Bio Covid-19 Rapid Antigen Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
    Table 100. Access Bio Main Business
    Table 101. Access Bio Latest Developments
    Table 102. BD Basic Information, Covid-19 Rapid Antigen Manufacturing Base, Sales Area and Its Competitors
    Table 103. BD Covid-19 Rapid Antigen Product Offered
    Table 104. BD Covid-19 Rapid Antigen Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
    Table 105. BD Main Business
    Table 106. BD Latest Developments
    Table 107. Quidel Basic Information, Covid-19 Rapid Antigen Manufacturing Base, Sales Area and Its Competitors
    Table 108. Quidel Covid-19 Rapid Antigen Product Offered
    Table 109. Quidel Covid-19 Rapid Antigen Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
    Table 110. Quidel Main Business
    Table 111. Quidel Latest Developments
    Table 112. Fujirebio Basic Information, Covid-19 Rapid Antigen Manufacturing Base, Sales Area and Its Competitors
    Table 113. Fujirebio Covid-19 Rapid Antigen Product Offered
    Table 114. Fujirebio Covid-19 Rapid Antigen Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
    Table 115. Fujirebio Main Business
    Table 116. Fujirebio Latest Developments
    Table 117. Ellume Basic Information, Covid-19 Rapid Antigen Manufacturing Base, Sales Area and Its Competitors
    Table 118. Ellume Covid-19 Rapid Antigen Product Offered
    Table 119. Ellume Covid-19 Rapid Antigen Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
    Table 120. Ellume Main Business
    Table 121. Ellume Latest Developments
    Table 122. OraSure Technologies Basic Information, Covid-19 Rapid Antigen Manufacturing Base, Sales Area and Its Competitors
    Table 123. OraSure Technologies Covid-19 Rapid Antigen Product Offered
    Table 124. OraSure Technologies Covid-19 Rapid Antigen Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
    Table 125. OraSure Technologies Main Business
    Table 126. OraSure Technologies Latest Developments
    Table 127. Clip Health Basic Information, Covid-19 Rapid Antigen Manufacturing Base, Sales Area and Its Competitors
    Table 128. Clip Health Covid-19 Rapid Antigen Product Offered
    Table 129. Clip Health Covid-19 Rapid Antigen Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
    Table 130. Clip Health Main Business
    Table 131. Clip Health Latest Developments
    Table 132. Celltrion Healthcare Basic Information, Covid-19 Rapid Antigen Manufacturing Base, Sales Area and Its Competitors
    Table 133. Celltrion Healthcare Covid-19 Rapid Antigen Product Offered
    Table 134. Celltrion Healthcare Covid-19 Rapid Antigen Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
    Table 135. Celltrion Healthcare Main Business
    Table 136. Celltrion Healthcare Latest Developments
    Table 137. Salofa Oy Basic Information, Covid-19 Rapid Antigen Manufacturing Base, Sales Area and Its Competitors
    Table 138. Salofa Oy Covid-19 Rapid Antigen Product Offered
    Table 139. Salofa Oy Covid-19 Rapid Antigen Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
    Table 140. Salofa Oy Main Business
    Table 141. Salofa Oy Latest Developments
    Table 142. iHealth Labs Basic Information, Covid-19 Rapid Antigen Manufacturing Base, Sales Area and Its Competitors
    Table 143. iHealth Labs Covid-19 Rapid Antigen Product Offered
    Table 144. iHealth Labs Covid-19 Rapid Antigen Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
    Table 145. iHealth Labs Main Business
    Table 146. iHealth Labs Latest Developments
    Table 147. Novegent Basic Information, Covid-19 Rapid Antigen Manufacturing Base, Sales Area and Its Competitors
    Table 148. Novegent Covid-19 Rapid Antigen Product Offered
    Table 149. Novegent Covid-19 Rapid Antigen Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
    Table 150. Novegent Main Business
    Table 151. Novegent Latest Developments
    Table 152. Hangzhou Alltest Biotech Basic Information, Covid-19 Rapid Antigen Manufacturing Base, Sales Area and Its Competitors
    Table 153. Hangzhou Alltest Biotech Covid-19 Rapid Antigen Product Offered
    Table 154. Hangzhou Alltest Biotech Covid-19 Rapid Antigen Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
    Table 155. Hangzhou Alltest Biotech Main Business
    Table 156. Hangzhou Alltest Biotech Latest Developments
    Table 157. Guangzhou Decheng Biotechnology Basic Information, Covid-19 Rapid Antigen Manufacturing Base, Sales Area and Its Competitors
    Table 158. Guangzhou Decheng Biotechnology Covid-19 Rapid Antigen Product Offered
    Table 159. Guangzhou Decheng Biotechnology Covid-19 Rapid Antigen Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
    Table 160. Guangzhou Decheng Biotechnology Main Business
    Table 161. Guangzhou Decheng Biotechnology Latest Developments
    Table 162. SD Biosensor Basic Information, Covid-19 Rapid Antigen Manufacturing Base, Sales Area and Its Competitors
    Table 163. SD Biosensor Covid-19 Rapid Antigen Product Offered
    Table 164. SD Biosensor Covid-19 Rapid Antigen Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
    Table 165. SD Biosensor Main Business
    Table 166. SD Biosensor Latest Developments
    Table 167. MP Biomedical Basic Information, Covid-19 Rapid Antigen Manufacturing Base, Sales Area and Its Competitors
    Table 168. MP Biomedical Covid-19 Rapid Antigen Product Offered
    Table 169. MP Biomedical Covid-19 Rapid Antigen Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
    Table 170. MP Biomedical Main Business
    Table 171. MP Biomedical Latest Developments
    Table 172. Jiangsu Well Biotech Basic Information, Covid-19 Rapid Antigen Manufacturing Base, Sales Area and Its Competitors
    Table 173. Jiangsu Well Biotech Covid-19 Rapid Antigen Product Offered
    Table 174. Jiangsu Well Biotech Covid-19 Rapid Antigen Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
    Table 175. Jiangsu Well Biotech Main Business
    Table 176. Jiangsu Well Biotech Latest Developments
    Table 177. CTK Biotech Basic Information, Covid-19 Rapid Antigen Manufacturing Base, Sales Area and Its Competitors
    Table 178. CTK Biotech Covid-19 Rapid Antigen Product Offered
    Table 179. CTK Biotech Covid-19 Rapid Antigen Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
    Table 180. CTK Biotech Main Business
    Table 181. CTK Biotech Latest Developments
    Table 182. Hangzhou Laihe Biotech Basic Information, Covid-19 Rapid Antigen Manufacturing Base, Sales Area and Its Competitors
    Table 183. Hangzhou Laihe Biotech Covid-19 Rapid Antigen Product Offered
    Table 184. Hangzhou Laihe Biotech Covid-19 Rapid Antigen Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
    Table 185. Hangzhou Laihe Biotech Main Business
    Table 186. Hangzhou Laihe Biotech Latest Developments
    Table 187. Innovation Scientific Basic Information, Covid-19 Rapid Antigen Manufacturing Base, Sales Area and Its Competitors
    Table 188. Innovation Scientific Covid-19 Rapid Antigen Product Offered
    Table 189. Innovation Scientific Covid-19 Rapid Antigen Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
    Table 190. Innovation Scientific Main Business
    Table 191. Innovation Scientific Latest Developments
    Table 192. Biohit Healthcare Basic Information, Covid-19 Rapid Antigen Manufacturing Base, Sales Area and Its Competitors
    Table 193. Biohit Healthcare Covid-19 Rapid Antigen Product Offered
    Table 194. Biohit Healthcare Covid-19 Rapid Antigen Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
    Table 195. Biohit Healthcare Main Business
    Table 196. Biohit Healthcare Latest Developments
    Table 197. ACON Biotech Basic Information, Covid-19 Rapid Antigen Manufacturing Base, Sales Area and Its Competitors
    Table 198. ACON Biotech Covid-19 Rapid Antigen Product Offered
    Table 199. ACON Biotech Covid-19 Rapid Antigen Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
    Table 200. ACON Biotech Main Business
    Table 201. ACON Biotech Latest Developments
    Table 202. Assure Tech Basic Information, Covid-19 Rapid Antigen Manufacturing Base, Sales Area and Its Competitors
    Table 203. Assure Tech Covid-19 Rapid Antigen Product Offered
    Table 204. Assure Tech Covid-19 Rapid Antigen Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
    Table 205. Assure Tech Main Business
    Table 206. Assure Tech Latest Developments
    Table 207. Hangzhou Clongene Biotech Basic Information, Covid-19 Rapid Antigen Manufacturing Base, Sales Area and Its Competitors
    Table 208. Hangzhou Clongene Biotech Covid-19 Rapid Antigen Product Offered
    Table 209. Hangzhou Clongene Biotech Covid-19 Rapid Antigen Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
    Table 210. Hangzhou Clongene Biotech Main Business
    Table 211. Hangzhou Clongene Biotech Latest Developments
    Table 212. Hangzhou Testsea Biotechnology Basic Information, Covid-19 Rapid Antigen Manufacturing Base, Sales Area and Its Competitors
    Table 213. Hangzhou Testsea Biotechnology Covid-19 Rapid Antigen Product Offered
    Table 214. Hangzhou Testsea Biotechnology Covid-19 Rapid Antigen Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
    Table 215. Hangzhou Testsea Biotechnology Main Business
    Table 216. Hangzhou Testsea Biotechnology Latest Developments
List of Figures
    Figure 1. Picture of Covid-19 Rapid Antigen
    Figure 2. Covid-19 Rapid Antigen Report Years Considered
    Figure 3. Research Objectives
    Figure 4. Research Methodology
    Figure 5. Research Process and Data Source
    Figure 6. Global Covid-19 Rapid Antigen Sales Growth Rate 2017-2028 (K Units)
    Figure 7. Global Covid-19 Rapid Antigen Revenue Growth Rate 2017-2028 ($ Millions)
    Figure 8. Covid-19 Rapid Antigen Sales by Region (2021 & 2028) & ($ millions)
    Figure 9. Product Picture of Nasal Swab
    Figure 10. Product Picture of Oral Fluid/Saliva
    Figure 11. Global Covid-19 Rapid Antigen Sales Market Share by Sample Type in 2021
    Figure 12. Global Covid-19 Rapid Antigen Revenue Market Share by Sample Type (2017-2022)
    Figure 13. Covid-19 Rapid Antigen Consumed in Hospitals
    Figure 14. Global Covid-19 Rapid Antigen Market: Hospitals (2017-2022) & (K Units)
    Figure 15. Covid-19 Rapid Antigen Consumed in Scientific Research
    Figure 16. Global Covid-19 Rapid Antigen Market: Scientific Research (2017-2022) & (K Units)
    Figure 17. Global Covid-19 Rapid Antigen Sales Market Share by Application (2017-2022)
    Figure 18. Global Covid-19 Rapid Antigen Revenue Market Share by Application in 2021
    Figure 19. Covid-19 Rapid Antigen Revenue Market by Company in 2021 ($ Million)
    Figure 20. Global Covid-19 Rapid Antigen Revenue Market Share by Company in 2021
    Figure 21. Global Covid-19 Rapid Antigen Sales Market Share by Geographic Region (2017-2022)
    Figure 22. Global Covid-19 Rapid Antigen Revenue Market Share by Geographic Region in 2021
    Figure 23. Global Covid-19 Rapid Antigen Sales Market Share by Region (2017-2022)
    Figure 24. Global Covid-19 Rapid Antigen Revenue Market Share by Country/Region in 2021
    Figure 25. Americas Covid-19 Rapid Antigen Sales 2017-2022 (K Units)
    Figure 26. Americas Covid-19 Rapid Antigen Revenue 2017-2022 ($ Millions)
    Figure 27. APAC Covid-19 Rapid Antigen Sales 2017-2022 (K Units)
    Figure 28. APAC Covid-19 Rapid Antigen Revenue 2017-2022 ($ Millions)
    Figure 29. Europe Covid-19 Rapid Antigen Sales 2017-2022 (K Units)
    Figure 30. Europe Covid-19 Rapid Antigen Revenue 2017-2022 ($ Millions)
    Figure 31. Middle East & Africa Covid-19 Rapid Antigen Sales 2017-2022 (K Units)
    Figure 32. Middle East & Africa Covid-19 Rapid Antigen Revenue 2017-2022 ($ Millions)
    Figure 33. Americas Covid-19 Rapid Antigen Sales Market Share by Country in 2021
    Figure 34. Americas Covid-19 Rapid Antigen Revenue Market Share by Country in 2021
    Figure 35. United States Covid-19 Rapid Antigen Revenue Growth 2017-2022 ($ Millions)
    Figure 36. Canada Covid-19 Rapid Antigen Revenue Growth 2017-2022 ($ Millions)
    Figure 37. Mexico Covid-19 Rapid Antigen Revenue Growth 2017-2022 ($ Millions)
    Figure 38. Brazil Covid-19 Rapid Antigen Revenue Growth 2017-2022 ($ Millions)
    Figure 39. APAC Covid-19 Rapid Antigen Sales Market Share by Region in 2021
    Figure 40. APAC Covid-19 Rapid Antigen Revenue Market Share by Regions in 2021
    Figure 41. China Covid-19 Rapid Antigen Revenue Growth 2017-2022 ($ Millions)
    Figure 42. Japan Covid-19 Rapid Antigen Revenue Growth 2017-2022 ($ Millions)
    Figure 43. South Korea Covid-19 Rapid Antigen Revenue Growth 2017-2022 ($ Millions)
    Figure 44. Southeast Asia Covid-19 Rapid Antigen Revenue Growth 2017-2022 ($ Millions)
    Figure 45. India Covid-19 Rapid Antigen Revenue Growth 2017-2022 ($ Millions)
    Figure 46. Australia Covid-19 Rapid Antigen Revenue Growth 2017-2022 ($ Millions)
    Figure 47. Europe Covid-19 Rapid Antigen Sales Market Share by Country in 2021
    Figure 48. Europe Covid-19 Rapid Antigen Revenue Market Share by Country in 2021
    Figure 49. Germany Covid-19 Rapid Antigen Revenue Growth 2017-2022 ($ Millions)
    Figure 50. France Covid-19 Rapid Antigen Revenue Growth 2017-2022 ($ Millions)
    Figure 51. UK Covid-19 Rapid Antigen Revenue Growth 2017-2022 ($ Millions)
    Figure 52. Italy Covid-19 Rapid Antigen Revenue Growth 2017-2022 ($ Millions)
    Figure 53. Russia Covid-19 Rapid Antigen Revenue Growth 2017-2022 ($ Millions)
    Figure 54. Middle East & Africa Covid-19 Rapid Antigen Sales Market Share by Country in 2021
    Figure 55. Middle East & Africa Covid-19 Rapid Antigen Revenue Market Share by Country in 2021
    Figure 56. Egypt Covid-19 Rapid Antigen Revenue Growth 2017-2022 ($ Millions)
    Figure 57. South Africa Covid-19 Rapid Antigen Revenue Growth 2017-2022 ($ Millions)
    Figure 58. Israel Covid-19 Rapid Antigen Revenue Growth 2017-2022 ($ Millions)
    Figure 59. Turkey Covid-19 Rapid Antigen Revenue Growth 2017-2022 ($ Millions)
    Figure 60. GCC Country Covid-19 Rapid Antigen Revenue Growth 2017-2022 ($ Millions)
    Figure 61. Manufacturing Cost Structure Analysis of Covid-19 Rapid Antigen in 2021
    Figure 62. Manufacturing Process Analysis of Covid-19 Rapid Antigen
    Figure 63. Industry Chain Structure of Covid-19 Rapid Antigen
    Figure 64. Channels of Distribution
    Figure 65. Distributors Profiles
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Please ask for Sample Report to see list of companies covered. Request Sample Report
Frequently Asked Questions
Global Covid-19 Rapid Antigen Market report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Global Covid-19 Rapid Antigen Market report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Global Covid-19 Rapid Antigen Market report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports